Top Qs
Timeline
Chat
Perspective
Flualprazolam
Triazolobenzodiazepine drug From Wikipedia, the free encyclopedia
Remove ads
Flualprazolam is a tranquilizer of the triazolobenzodiazepine (TBZD) class, which are benzodiazepines (BZDs) fused with a triazole ring. It was first synthesised in 1976,[2] but was never marketed. It can be seen as the triazolo version of fludiazepam. It has subsequently been sold as a designer drug,[3][4][5][6] first being definitively identified as such in Sweden in 2018.[7][8] It can be described as the 2'-fluoro derivative of alprazolam or the fluoro instead of chloro analogue of triazolam, and has similar sedative and anxiolytic effects.[9][10][11][12][13]
Remove ads
Legal status
Flualprazolam is banned in Sweden and illegal in the UK.[14] In December 2019, the World Health Organization recommended flualprazolam for international scheduling as a Schedule IV medication under the Convention on Psychotropic Substances.[15]
In the United States, Oregon and Virginia have placed Flualprazolam into Schedule I.[16] On 23 December 2022, the DEA announced it had begun consideration on the matter of placing Flualprazolam under temporary Schedule I status.[17] Later on 25 July 2023, the DEA published a pre-print notice that Flualprazolam would become temporarily scheduled as a Schedule I controlled substance from 26 July 2023 to 26 July 2025.[18] On 25 July 2025, and effective the following day, the DEA extended the temporary scheduling until 26 July 2026.[19]
Remove ads
See also
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads